Surgalign Receives FDA Clearance for the HOLO Portal™ System, the First AI-Driven AR Guidance System for Spine Surgery and Reports Preliminary Fourth Quarter and Full Year 2021 Results
Clearance is for use in the lumbar portion of the $5 billion instrumented fusion market* DEERFIELD, Ill., Jan. 18, 2022 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA), a global medical technology company focused on raising the standard of care by driving the evolution of health digital, today announced thatRead More →